Article first published online: 6 APR 2009
Copyright © 2009 American Association for the Study of Liver Diseases
Volume 50, Issue 2, pages 369–377, August 2009
How to Cite
Berg, T., Weich, V., Teuber, G., Klinker, H., Möller, B., Rasenack, J., Hinrichsen, H., Gerlach, T., Spengler, U., Buggisch, P., Balk, H., Zankel, M., Neumann, K., Sarrazin, C. and Zeuzem, S. (2009), Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1–infected patients. Hepatology, 50: 369–377. doi: 10.1002/hep.22991
Presented in part at the Annual Meetings of the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases in 2006.
Potential conflicts of interest: Dr. Berg advises, is on the speakers' bureau of, and received grants from Roche and Schering-Plough. Dr. Klinker is a consultant for and lectures for Bristol-Myers Squibb, and GlaxoSmithKline. He also lectures for Boehringer Ingelheim, Roche, Gilead, and Tibotec. He lectures for and received grants from Essex. He is a consultant for Merck Sharp & Dohme and received grants from Abbott. Dr. Buggisch is on the speakers' bureau of Roche. Dr. Sarrazin is on the speakers' bureau of and received grants from Essex. Dr. Zeuzem is a consultant for, advises, is on the speakers' bureau of, and received grants from Roche and Schering-Plough.
- Issue published online: 29 JUL 2009
- Article first published online: 6 APR 2009
- Accepted manuscript online: 6 APR 2009 12:00AM EST
- Manuscript Accepted: 15 MAR 2009
- Manuscript Received: 25 OCT 2008
- Essex Pharma (Munich, Germany), a subsidiary of Schering-Plough (Kenilworth, NJ)
- Bayer Diagnostics
- German Competence Network for Viral Hepatitis (Kompetenznetz Hepatitis, Hep-Net), funded by the German Ministry of Education and Research. Grant Number: 01 KI 0102
- VIRGIL European Network of Excellence Combating Viral Resistance to Treatments
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.